![Bittoo Kanwar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bittoo Kanwar
Nessuna posizione attualmente
Profilo
Bittoo Kanwar formerly worked at Ensho Therapeutics, Inc., as Chief Executive Officer, Protagonist Therapeutics, Inc., as Vice President-Clinical Development, and Applied Molecular Transport, Inc., as Chief Medical Officer from 2019 to 2023.
Dr. Kanwar received his graduate degree from the University of Iowa.
Precedenti posizioni note di Bittoo Kanwar
| Società | Posizione | Fine |
|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Direttore Tecnico/Scientifico/R&S | 08/03/2023 |
| PROTAGONIST THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Bittoo Kanwar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
